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Abstract: Background:  Post amputation, the complication phantom limb pain (PLP) is prevalent
and difficult to manage.  This study aimed to determine whether it was feasible and
acceptable to undertake a definitive multi-centred randomised controlled trial assessing
the effectiveness of acupuncture for treating lower limb amputees with PLP.
Methods:  A mixed methods embedded design including a randomised controlled trial
and semi-structured interviews was undertaken.  A total of 15 participants with PLP
were randomly assigned to receive either 8 pragmatic Traditional Chinese Medicine
acupuncture treatments and usual care or usual care alone over four weeks.
Outcomes measures were completed at baseline, weekly throughout the study and at
one month post completion of the study and included; a numerical pain rating scale,
Short-Form McGill Pain Questionnaire 2, EQ-5D-5L, Hospital Anxiety and Depression
Scale, Perceived Stress Scale 10 item, Insomnia Severity Index, Patient Global
Impression of Change.  Post completion of the trial, participants in the acupuncture
group were interviewed about their experience.  Feasibility specific data were also
collected.
Results: Of 24 amputees meeting the study inclusion criteria 15 agreed to participate
(recruitment rate 62.50%).  Qualitatively acupuncture was perceived to be beneficial
and effective.  Quantitatively acupuncture demonstrated clinically meaningful change in
average pain intensity (raw change=2.69) and worst pain intensity (raw change =
4.00).  Feasibility specific data identified that before undertaking a definitive trial,
recruitment, practitioner adherence to the acupuncture protocol, completion of outcome
measures at one month follow up and blinding should be addressed.  Appropriate
outcome measures were identified for use in a definitive trial.  Data were generated for
future sample size calculations (effect size 0.64).  Allowing for a 20% dropout rate, a
sample size of 85 participants per group would be needed in a future definitive trial.
Conclusions:  A future definitive trial may be possible if the areas identified in this study
are addressed.  As acupuncture may be effective at treating PLP and as this feasibility
study suggests a definitive trial may be possible, a multi-centred trial with adequate
sample size and blinding is now needed.
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Response to Reviewers: REVIEWER 1:
Methods:
1. In the discussion, you state that only 1 practitioner was involved. It would should be
noted in the methods that only 1 practitioner performed the intervention. Their level of
training should be described.
The methods section now states:
‘Acupuncture was provided by an NHS clinic co-located in the same building by one
British Acupuncture Council registered acupuncture practitioner (BSc (Hons)
acupuncture) with more than 15 years clinical experience.’
2. A short description of the intervention protocol would be helpful so the reader does
not need to refer to the protocol paper.
A description of the intervention has now been provided:
Acupuncture was delivered pragmatically under the Traditional Chinese Medicine
(TCM) paradigm.  A protocol developed prior to the study, using Delphi consensus
methodology was used to provide guidelines[14] and included:
•Using a combination of body and auricular acupuncture;
•Treating the contralateral limb and possibly the ipsilateral limb;
•Including auricular acupuncture points such as shen men, sympathetic and points
corresponding to the lower limb;
•Depending on the health of the tissue and the individual participant needling around
the stump;
•Mirroring local and distal points by needling the opposite limb;
•Including points on the lower back (taking a segmental approach to dermatomal pain)
•Including points such as LI4+LR3, LR3, GV20, SP10 and also specified points
according to participants specific symptoms;
•Try and obtain deqi;
•Retaining needles for 20-30 minutes.
Treatment could include electro-acupuncture or other adjunctive interventions including
cupping, exercises and lifestyle advice.
3. More information on the outcome measures would be useful: the range, which
direction indicates worse outcome, references to questionnaires.
More details have been provide on the range and direction of NRS and PGIC scale.
References have been provided for all outcome measures.
4. More information on the interviews is required. Who conducted them? Was it a semi-
structured process? Were they transcribed and coded?
The following information has been provided about the interviews and qualitative
analysis:
‘Interviews were conducted by the researcher who enrolled participants and collected
outcome measures.  Interviews were semi-structured, audio-recorded, followed a topic
guide and transcribed verbatim.’
‘Specific steps were followed during data analysis including; familiarisation, coding,
identifying an analytical framework, indexing, charting and mapping / interpretation.  All
codes and themes were developed inductively during analysis of the data.’
5. It would be useful for the proposed sample size to be reported (corresponding to an
effect size of 0.35 using 0.8 power and 0.05 significance). The pooled standard
deviation used to calculate the effect size should also be reported.
Details are now provided on a sample size calculation in the methods and results
section of the paper.  In the methods section the following details are included:
‘Using effect size data generated from this study and taking the assumption that a
future study would: (1) use an 11 point NRS measuring average pain over the last
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week, (2) have normally distributed data, (3) use a two tailed independent samples T
Test to compare acupuncture versus usual care, (4) set power and level of significance
/ α-level at 0.8 and 0.05 respectively, a sample size for a future definitive trial was
calculated[27]:’
In the results section the following details are given:
‘A sample size for a future trial was calculated corresponding to an effect size of 0.64
and pooled standard deviation of 1.36.  A total of 71 per group (142 in total) would be
needed.  According to findings from this feasibility study, the follow up rate at four
weeks was 80%.  Therefore, considering a 20% dropout rate, 170 participants (85 per
group) are recommended to detect a significant change in a two armed, parallel group
randomised controlled trial comparing acupuncture and usual care as measured using
an 11 point NRS measuring average pain at four weeks.’
Results:
6. Baseline imbalances (e.g. gender, ISI) should be discussed.
These have now been discussed:
‘Between groups there were differences in gender.  In the acupuncture group six were
males and in the usual care group five were females.  In the acupuncture group the
majority of participants were below knee amputees, whereas in the usual care group
the majority were above knee amputees.  Baseline primary and secondary outcome
measure scores were similar between groups.’
7. Add label to y-axis of figure 1.
A label has been added to the y axis of figure 1.
8. Add percentages to Table 1 with baseline demographics.
Percentage values have been added to table 1.
9. There should be some brief comment on the results of secondary outcomes.
Secondary outcomes have been commented on:
In the acupuncture group decrease in mean worst pain was found to be clinically
meaningful (raw change = 4.00) but this was not so in the usual care group (raw
change = 1.00).  The SF-MPQ-2 identified a small effect between groups at day 28
(d=0.46).  Mean HADS anxiety and depression scores were normal throughout the
study in both groups (score ≤ 7).  As with the HADS, little change was observed in
PSS-10 scores over the course of the study.  Both groups at baseline had sub-
threshold insomnia (ISI score 8-14) which improved by day 28.  Throughout the study
EQ-5D-5L scores were stable across dimensions.  At the primary end point of the study
the PGIC identified that participants in the acupuncture group rated themselves as
‘better’ whereas participants in the usual care group rated themselves as ‘a little better’.
10. In the qualitative results, you state "The acupuncturist where the acupuncture was
conducted were considered to affect the effectiveness of treatment." Do you feel you
can say this when only one practitioner was involved in the study?
This has now been changed to:
‘The environment where the acupuncture was conducted were considered to affect the
effectiveness of treatment.’
REVIEWER 2:
The study's primary endpoint simply shouldn't be calculated before the completion of
management of these patients. End of treatment must be considered the period after
all acupuncture and/or conventional therapy has sessions have been made; therefore
the primary endpoint should be sought after that. When patients answer questionnaires
after just a week of treatment should not be considered a primary endpoint.
In this regard, only one patient from the acupuncture group completed his follow-up
and was able to provide feedback, which should be the endpoint. Even feasibility
studies shouldn't come to any conclusions when only one patient from one group and
four from the other group complete the follow-up. No results can be translated into
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
knowledge for future studies from this work unfortunately.
It has now been clarified in the article when the study’s primary endpoint was.  The
primary end point was, as stated in the protocol, after completion of the intervention at
day 28 (after completion of the acupuncture intervention).  At the primary end point
(day 28) 7 participants in the acupuncture group and 5 in the usual care group
completed outcomes.
‘The intervention was discontinued after week 4 and this was chosen as the primary
end point of the study (day 28).’
‘A total of 12 participants were still enrolled and completed outcomes at day 28, the
primary end point of the study (7 acupuncture group and 5 usual care group).’
The participant flow diagram has also been amended to highlight the primary endpoint
of the study.
REVIEWER 3:
Firstly, regarding randomisation, please clarify that opaque envelopes were used for
randomisation as stated in the protocol as this will be helpful for future readers.
It has now been included that the envelopes were opaque.
‘allocation concealment was implemented using sequentially numbered opaque
envelopes which were only opened once participants had been enrolled.’
Secondly, in light of the study not meeting a number of its success criteria, particularly
regarding recruitment and retention, the feasibility of a larger study seems doubtful.
The conclusion in the abstract that a larger study is warranted therefore needs to be
stated more cautiously.
The conclusion of the abstract has been stated more cautiously:
‘A future definitive trial may be possible if the areas identified in this study are
addressed.  As acupuncture may be effective at treating PLP and as this feasibility
study suggests a definitive trial may be possible, a multi-centred trial with adequate
sample size and blinding is now needed.’
As a number of problems were identified with feasibility, please provide further
elaboration in the discussion as to why a definitive trial would be justified despite these
issues.
The discussion section has been rewritten focusing on feasibility and steps which
would need to be put in place when designing a definitive trial.
Additionally, though improving retention is highlighted as an issue, suggestions for
improving this are not discussed and this would be helpful for those designing a future
study in this area.
Suggestions for improving retention have now been included in the discussion:
Although participants adhered to completing outcome measures, this was not
sustained post the primary end point of the study.  This lack of long term retention
needs addressing as poor retention has implications on statistical power and the
internal and external validity of a study[43].  Strategies could be implemented such as
including; a follow up contact, pre-notification reminders, mentioning an obligation to
respond[44].  In randomised controlled trials offering and giving small monetary
incentives has been found to be successful in improving response[43].
EDITORS COMMENTS
I am concerned that the primary endpoint is not clearly defined in the paper and in
particular within the results section and flowchart.
The trial was registered on ClinicalTrials.gove which states: "Primary Outcome
Measures: Change in Numerical Rating Scale [ Time Frame: Change from baseline at
four weeks ]...An eleven point scale will be used.... Participants will be asked to rate
their average phantom pain over the last week". The primary endpoint specified prior to
commencement of the study is clearly given as four weeks from baseline.  However the
results section of the paper states that: "A total of 10 participants [from 15] did not
complete the one month follow up questionnaire". A check of the flowchart also shows
that at one month follow-up only one participant from the acupuncture group, and four
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from the control group, provided outcome data. Any attempt to draw conclusions
regarding the clinical impact of the intervention using data from just one participant is
clearly not sound. With regard to the conclusions, in the absence of any mention of
this, or indeed the lack of any observed statistical difference in outcomes between
groups, the statement that "The study identified that acupuncture may cause clinically
meaningful change" appears to be cherry picking.
The primary end point of the study was after completion of the intervention (four weeks
from baseline).  All data analysis was completed at this time point (data from 7
participants in the acupuncture group and 5 in the usual care group completed
outcomes at this time point).  Data were only collected at one month post completion of
the intervention to inform on dropout rate at this time point.
To address this particular issue please:
1.Rewrite the analysis and results section of the paper. For this I would recommend
approaching a different statistician for support. Please note this will be subject to
further statistical scrutiny on submission of the revised manuscript.
On obtaining further advice we have been advised that as the study is a feasibility
study with no sample size calculation it is inappropriate to include any significance
tests or report on hypothesis testing.  Therefore all details on significance testing has
been removed from the paper.
2.Provide a table of results for outcome data in the main body of the paper rather than
supplementary materials. This should clearly show the actual number of participants in
each group who provided complete data for each measure at each endpoint. These
numbers are not currently given in the supplementary tables.
A table of results for outcome data has now been included in the main body of the
paper and shows the actual number of participants in each group who completed
outcomes at these time points.
3.Use means and 95% CIs when presenting results wherever possible.
Data has been changed from median (quartiles) to mean (±95% CI).  Also, as mean
and 95% CI have been used, Cohen’s d effect size has been used to calculate effect
size.
4.Revise the flowchart, including defined endpoints in days or weeks.
The flow chart has been revised to include defined endpoints.
5.Rewrite the discussion and conclusions sections. I suggest removing the above
statement, or at least balance it, by giving priority to results for the primary
outcome/endpoint. Obviously as a feasibility study the intention was not to demonstrate
effectiveness, but rather was a toe in the water for a bigger RCT. It achieved that
purpose.
The discussion section has been rewritten to focus on feasibility.  Given that 12
participants were enrolled at the primary end point of the study the conclusion has not
been changed.
6.Further issues to address: The acupuncture intervention that was actually delivered
is not clearly described in the manuscript. The reader should not have to refer to
another paper describing a protocol, which may or (indeed as the manuscript alludes
to) may not have been followed. Please complete the STRICTA checklist
(http://www.stricta.info/checklist.html) and attach it to the submission, revising the
manscript accordingly.
The manuscript has been revised and a STRICTA checklist included.
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ABSTRACT 31 
Background:  Post amputation, the complication phantom limb pain (PLP) is prevalent and 32 
difficult to manage.  This study aimed to determine whether it was feasible and acceptable to 33 
undertake a definitive multi-centred randomised controlled trial assessing the effectiveness of 34 
acupuncture for treating lower limb amputees with PLP. 35 
Methods:  A mixed methods embedded design including a randomised controlled trial and 36 
semi-structured interviews was undertaken.  A total of 15 participants with PLP were randomly 37 
assigned to receive either 8 pragmatic Traditional Chinese Medicine acupuncture treatments 38 
and usual care or usual care alone over four weeks.  Outcomes measures were completed at 39 
baseline, weekly throughout the study and at one month post completion of the study and 40 
included; a numerical pain rating scale, Short-Form McGill Pain Questionnaire 2, EQ-5D-5L, 41 
Hospital Anxiety and Depression Scale, Perceived Stress Scale 10 item, Insomnia Severity 42 
Index, Patient Global Impression of Change.  Post completion of the trial, participants in the 43 
acupuncture group were interviewed about their experience.  Feasibility specific data were 44 
also collected. 45 
Results: Of 24 amputees meeting the study inclusion criteria 15 agreed to participate 46 
(recruitment rate 62.50%).  Qualitatively acupuncture was perceived to be beneficial and 47 
effective.  Quantitatively acupuncture demonstrated clinically meaningful change in average 48 
pain intensity (raw change=2.69) and worst pain intensity (raw change = 4.00).  Feasibility 49 
specific data identified that before undertaking a definitive trial, recruitment, practitioner 50 
adherence to the acupuncture protocol, completion of outcome measures at one month follow 51 
up and blinding should be addressed.  Appropriate outcome measures were identified for use 52 
in a definitive trial.  Data were generated for future sample size calculations (effect size 0.64).  53 
Allowing for a 20% dropout rate, a sample size of 85 participants per group would be needed 54 
in a future definitive trial.  55 
Conclusions:  A future definitive trial may be possible if the areas identified in this study are 56 
addressed.  As acupuncture may be effective at treating PLP and as this feasibility study 57 
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suggests a definitive trial may be possible, a multi-centred trial with adequate sample size and 58 
blinding is now needed. 59 
Trial registration: ClinicalTrials.gov: NCT02126436. Registration date: 9.4.2014. 60 
 61 
Key words: 62 
Phantom limb, randomized controlled trial, acupuncture, amputation, mixed methods 63 
research. 64 
 65 
BACKGROUND  66 
Phantom limb pain (PLP) is defined as painful sensations in the missing portion of the 67 
amputated limb.  It is neuropathic in nature and caused by a lesion of the somatosensory 68 
nervous system[1].  It can be chronic and has been found to influence individuals subjective 69 
well-being affecting both physical and mental components of quality of life[2].   70 
Currently, PLP is not well managed.  A systematic review evaluating the use of pre-emptive 71 
analgesia found only one case-controlled study supported combined bupivacaine, 72 
diamorphine and clonidine.  Epidural and perineural infusions containing local anaesthetic +/- 73 
opiates were deemed only effective for treating acute perioperative pain[3].  A small 74 
randomised controlled trial found intravenous ketamine could significantly reduce PLP during 75 
and for 30 minutes after infusion[4].  However, a subsequent systematic review found it 76 
ineffective[5].  The most commonly used first line treatment is gabapentin[6] but a systematic 77 
review found this beneficial for short-term analgesic efficacy only[7].  Many case studies report 78 
positively on the effectiveness of mirror therapy[8] but few randomised controlled trials have 79 
been completed and adverse effects have been reported.  80 
Acupuncture has been found to be effective for treating a variety of chronic pain conditions[9] 81 
but little quality evidence is available on the use of acupuncture for PLP.  A recent systematic 82 
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review identified only two non-randomised controlled trials[10] and 26 case studies[11].  83 
Further research is needed to evaluate the effectiveness of acupuncture for treating PLP, but 84 
prior to a definitive trial a study is needed to inform on feasibility. 85 
This study aimed to evaluate the feasibility and acceptability of completing a small randomised 86 
controlled trial in preparation for a definitive multi-centred randomised controlled trial[12].  87 
Objectives were to; (1) explore the feasibility of recruiting, randomising and retaining 88 
participants, (2) evaluate the feasibility and acceptability of having a usual care control, (3) 89 
evaluate adherence / compliance and acceptability of acupuncture as an intervention, (4) 90 
evaluate the appropriateness of outcome measures, (5) identify appropriate primary and 91 
secondary outcome measures which could be used in future trials, (6) explore the perceived 92 
effectiveness of acupuncture for treating PLP, (7) generate data on effect size for use in future 93 
sample size calculations, (8) inform the development of an appropriate and feasible protocol 94 
for use in a definitive multi-centred randomised controlled trial. 95 
 96 
METHODS  97 
A comparative effectiveness study using a mixed methods embedded design including a small 98 
randomised controlled trial incorporating semi-structured interviews was undertaken.  The 99 
randomised controlled trial was unstratified, open, pragmatic, with two parallel arms, balanced 100 
randomization and usual care control.  Interviews were cross-sectional.  The study protocol 101 
has been published[12].  The trial was registered with ClinicalTrials.gov (NCT02126436).  A 102 
CONSORT checklist is included within the articles additional files (additional file 1, CONSORT 103 
2010 checklist of information to include when reporting a randomised trial.pdf).  Ethical 104 
approval was granted from NRES Committee London – Bloomsbury (14/LO/0817) and London 105 
South Bank University, the trial commenced in October 2014 and closed one year later in 106 
October 2015.   107 
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Participants were recruited from an NHS inpatient amputee rehabilitation unit in London.  All 108 
participants were provided with information and were required to consent orally and in writing.  109 
Participants were included if they; (1) 18 years of age or above, (2) full cognitive ability and 110 
able to communicate in English, (3) traumatic or medical amputation of a lower limb (greater 111 
than toes) (4) currently experiencing worst pain PLP of ≥5 on an eleven point verbal rating 112 
scale.  Participants were excluded if they: (1) had congenital limb absence, (2) medically 113 
unwell, (3) pregnant, (4) where acupuncture is cautioned[13]. 114 
Participants were randomly allocated to either receive usual care and acupuncture or usual 115 
care alone.  A usual care comparator was chosen as the study was undertaken under the 116 
Medical Research Council guidelines for developing and evaluating complex interventions.  117 
Usual care included pharmacological medical intervention, physiotherapy and occupational 118 
therapy.  Acupuncture was provided by an NHS clinic co-located in the same building by one 119 
British Acupuncture Council registered acupuncture practitioner (BSc (Hons) acupuncture) 120 
with more than 15 years clinical experience.  Acupuncture was delivered pragmatically under 121 
the Traditional Chinese Medicine (TCM) paradigm.  A protocol developed prior to the study, 122 
using Delphi consensus methodology was used to provide guidelines[14] and included:  123 
 Using a combination of body and auricular acupuncture; 124 
 Treating the contralateral limb and possibly the ipsilateral limb; 125 
 Including auricular acupuncture points such as shen men, sympathetic and points 126 
corresponding to the lower limb; 127 
 Depending on the health of the tissue and the individual participant needling around 128 
the stump; 129 
 Mirroring local and distal points by needling the opposite limb; 130 
 Including points on the lower back (taking a segmental approach to dermatomal pain) 131 
 Including points such as LI4+LR3, LR3, GV20, SP10 and also specified points 132 
according to participants specific symptoms; 133 
 Try and obtain deqi; 134 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
6 
 
 Retaining needles for 20-30 minutes. 135 
Treatment could include electro-acupuncture or other adjunctive interventions including 136 
cupping, exercises and lifestyle advice.  All participants in the acupuncture group were 137 
allocated eight one hour sessions (twice weekly for four weeks).   138 
Outcome measures were completed at baseline, weekly for the duration of the trial and one 139 
month post completion of the study.  The primary outcome measure was an eleven point 140 
numerical rating scale (NRS) capturing average PLP over the past week, using the anchors 0 141 
meaning ‘no pain’ and 10 meaning ‘pain as bad as you can imagine’[15].  Secondary outcome 142 
measures included; NRS capturing worst PLP over the past week, the Short Form McGill Pain 143 
Questionnaire 2 (SF-MPQ-2)[16], EuroQol-5 Dimensions (EQ-5D-5L)[17], Hospital Anxiety 144 
and Depression Scale (HADS)[18], Perceived Stress Scale 10 item (PSS-10)[19], Insomnia 145 
Severity Index (ISI)[20] and a seven point Patient Global Impression of Change (PGIC) scale 146 
ranging from 1 meaning ‘no change’ to 7 meaning ‘a great deal better’  Phrasing of PGIC 147 
question was similar to the phrasing used by Hurst and Bolton[21] and stated ‘since being 148 
enrolled in this study how would you describe the change (if any) in activity limitations, 149 
symptoms, emotion and overall quality of life in relation to your phantom limb pain.  Feasibility 150 
specific data were collected (table 4) and post completion of the study, participants in the 151 
acupuncture group were interviewed.  Interviews were conducted by the researcher who 152 
enrolled participants and collected outcome measures.  Interviews were semi-structured, 153 
audio-recorded, followed a topic guide and transcribed verbatim.  154 
No sample size calculation was undertaken but a sample of 20 was deemed adequate to 155 
inform on feasibility[22].  Interim safety and effectiveness were not formally evaluated but data 156 
were collected through participant interviews.  Randomisation and allocation concealment was 157 
undertaken by a researcher not involved in the study using a computer generated random 158 
numbers table.  Randomisation was unstratified and balanced using a block of four and 159 
allocation concealment was implemented using sequentially numbered opaque envelopes 160 
which were only opened once participants had been enrolled.  The researcher collecting 161 
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outcome measures and analysing data enrolled participants and was blinded to the 162 
participant’s allocation.  Participants and acupuncture practitioners were not blinded. 163 
Quantitative data analysis used an intention to treat approach and missing data were imputed 164 
using last observation carried forward.  The intervention was discontinued after week 4 and 165 
this was chosen as the primary end point of the study (day 28).  As this was a feasibility study 166 
no significance tests were performed and no hypothesis testing is reported.  Raw change, the 167 
difference between mean baseline and subsequent scores was calculated for the NRS and 168 
considered meaningful / clinically significant when ≥ 1.80[23].  Cohen’s d effect size was 169 
calculated using the calculation; d = M1 – M2 / σ pooled using Cohen’s criteria; 0.2, small effect, 170 
0.5, medium effect and 0.8, large effect[24].  Framework Analysis[25] was used to analyse 171 
qualitative data.  Specific steps were followed during data analysis including; familiarisation, 172 
coding, identifying an analytical framework, indexing, charting and mapping / interpretation.  173 
All codes and themes were developed inductively during analysis of the data.  Inferences were 174 
drawn from analysis of qualitative and quantitative findings.  Meta-inferences were drawn 175 
through combining qualitative and quantitative findings using side-by-side comparison[26].  176 
Using effect size data generated from this study and taking the assumption that a future study 177 
would: (1) use an 11 point NRS measuring average pain over the last week, (2) have normally 178 
distributed data, (3) use a two tailed independent samples T Test to compare acupuncture 179 
versus usual care, (4) set power and level of significance / α-level at 0.8 and 0.05 respectively, 180 
a sample size for a future definitive trial was calculated[27]:  181 
                                      182 
                                                                                                    183 
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RESULTS 186 
A total of 36 lower limb amputees were identified of which 12 were ineligible.  Of those eligible, 187 
9 refused to participate.  A total of 15 participants were enrolled, and their data analysed within 188 
their originally assigned groups.  Before the primary end point 2 were withdrawn due to being 189 
medically unwell and 1 dropped out having been randomised to usual care.  A total of 12 190 
participants completed outcomes at day 28, the primary end point of the study (7 acupuncture 191 
group and 5 usual care group).  A total of 10 participants did not complete the one month 192 
follow up questionnaire and 2 participants refused to be interviewed at the end of the study 193 
(figure 1).   194 
Demographic details are presented in table 1.  Between groups there were differences in 195 
gender.  In the acupuncture group six were males and in the usual care group five were 196 
females.  In the acupuncture group the majority of participants were below knee amputees, 197 
whereas in the usual care group the majority were above knee amputees.  Baseline primary 198 
and secondary outcome measure scores were similar between groups.   199 
Figure 1. Participant flow through the trial 200 
Table 1.  Participant demographics 201 
Quantitative findings 202 
In the acupuncture group mean average pain decreased from 5.44 to 2.75 and in the usual 203 
care group from 5.43 to 4.43 (figure 2).  In the acupuncture group decrease in average pain 204 
was found to be clinically meaningful (raw change = 2.69), but not in the usual care group (raw 205 
change = 1.00).  At day 28, a medium effect was found between groups (d = 0.64).   206 
In the acupuncture group decrease in mean worst pain was found to be clinically meaningful 207 
(raw change = 4.00) but this was not so in the usual care group (raw change = 1.00).  The SF-208 
MPQ-2 identified a small effect between groups at day 28 (d=0.46).  Mean HADS anxiety and 209 
depression scores were normal throughout the study in both groups (score ≤ 7).  As with the 210 
HADS, little change was observed in PSS-10 scores over the course of the study.  Both groups 211 
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at baseline had sub-threshold insomnia (ISI score 8-14) which improved by day 28.  212 
Throughout the study EQ-5D-5L scores were stable across dimensions.  At the primary end 213 
point of the study the PGIC identified that participants in the acupuncture group rated 214 
themselves as ‘better’ whereas participants in the usual care group rated themselves as ‘a 215 
little better’.  The datasets supporting these findings are included in table 2. 216 
Figure 2. Box plot of ‘average pain’ intensity at baseline and day 28 217 
Table 2: Summary statistics at baseline and day 28 expressed as mean and between 218 
group effect sizes 219 
Qualitative findings 220 
Six themes were identified through interviews with participants who received acupuncture 221 
(table 3).  Participants were initially sceptical and apprehensive about being involved in the 222 
trial, had low expectations of acupuncture and hoped to be randomised to usual care.  223 
However, these views changed, participants liked treatment (even if not being physically 224 
needed) and found it relaxing.  Electro-acupuncture was considered beneficial and pleasant 225 
and receiving two treatments a week was considered acceptable though some participants 226 
found this tiring.  Acupuncture was perceived to be effective at resolving or reducing PLP and 227 
other health problems and 4-6 treatments were needed for it to be effective.  Acupuncture was 228 
not perceived to cause any adverse effects.  The environment where the acupuncture was 229 
conducted was considered to affect the effectiveness of treatment.  230 
Completing outcome measures was considered acceptable, and relevant, but the SF-MPQ-2 231 
included words which some participants did not understand.  Length of time and frequency of 232 
questionnaire completion was acceptable with only one participant thinking they were given 233 
too often.  Overall being involved in the study was considered a good experience and 234 
acupuncture was perceived to be beneficial.  Participant quotes are included in table 3. 235 
Table 3.  Acupuncture group participant quotes from semi-structured interviews 236 
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Feasibility specific findings 238 
Recruitment was problematic, clinicians sometimes failed to identify suitable participants, the 239 
unit did not always run at full capacity and potential participants were often unwilling to be 240 
involved having just had a major amputation.  Of those identified, 12 were ineligible for 241 
inclusion, mainly due to PLP being < 5/10 intensity and of the remainder n=24, 62.50% 242 
consented to be enrolled.  Randomisation worked well with only one participant dropping out 243 
due to being randomised to usual care and all participants were treated in the group they were 244 
allocated into.  Those enrolled reported being happy to be randomised to either acupuncture 245 
or usual care.  Blinding was unsuccessful, with both participants and practitioners unintentially 246 
informing the researcher which group they had been allocated to. 247 
Participant compliance to the protocol was good[14].  The four participant deviations were due 248 
to; tiredness, forgetting appointments, appointments coinciding with another medical 249 
appointment, not wanting further treatment as PLP had resolved.  Practitioner adherence to 250 
the protocol was poor and no participant received all 8 treatments (mean total number of 251 
treatments 5.14 (4.02 – 6.27)).  Despite the protocol[14] advising using a combination of 252 
auricular and body acupuncture this was only given to one participant on two occasions.  Both 253 
lower limbs were treated 66.67% of the time whereas the contralateral limb only 8.33%.  254 
Needle retention time and adverse events were not reported.  For the dataset on acupuncture 255 
points used by practitioners in this feasibility study, see additional file 2 (Acupuncture points 256 
used by practitioners during the feasibility study.pdf).  257 
Outcome measures were identified which would be appropriate for a definitive trial.  The NRS, 258 
SF-MPQ-2 and PGIC captured change.  Baseline HADS scores were normal and little change 259 
was observed in the PSS-10 and EQ-5D-5L suggesting these outcomes may be inappropriate.  260 
The ISI may not be appropriate in an inpatient setting as anecdotally noise and medication 261 
affected sleep.  Retention of participants up until the primary end point of the study was good, 262 
but at one month follow up was poor.    263 
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A sample size for a future trial was calculated corresponding to an effect size of 0.64 and 264 
pooled standard deviation of 1.36.  A total of 71 per group (142 in total) would be needed.  265 
According to findings from this feasibility study, the follow up rate at four weeks was 80%.  266 
Therefore, considering a 20% dropout rate, 170 participants (85 per group) are recommended 267 
to detect a significant change in a two armed, parallel group randomised controlled trial 268 
comparing acupuncture and usual care as measured using an 11 point NRS measuring 269 
average pain at four weeks. 270 
Using the criteria set a priori[12], as shown in table 4 the study was found to be successful in 271 
relation to participants receiving the intended intervention, outcome measures being 272 
considered acceptable and appropriate and being completed at the primary end point of the 273 
study and the intervention being considered acceptable and appropriate for use in a definitive 274 
trial.  The study was unsuccessful in relation to recruitment, practitioner adherence to the 275 
protocol, completion of outcome measures at one month follow up and blinding.   276 
Table 4.  Success of feasibility study 277 
 278 
DISCUSSION  279 
The study did not meet its target of recruiting ≥ 2 participants per month or 20 participants in 280 
total.  This is not unusual and other studies have also reported recruitment as being slower or 281 
more difficult than expected[28].  It has been suggested that clinical staff have limited time to 282 
undertake research activities[29] and this may have influenced the identification of potential 283 
participants.  A future trial would need to ensure trial centres allocated adequate time and 284 
personnel.  Potential participants should be provided with some education about the 285 
intervention as a brief introduction may make participants less sceptical and more willing to 286 
consent.  Recruitment could be enhanced by a multi-centred approach.  Intensity of PLP was 287 
a major barrier to recruitment.  Although PLP can be severe, this may only be in approximately 288 
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30% of amputees[30, 31] explaining why this inclusion criterion excluded 9 participants.  289 
Future studies may consider lowering or excluding the severity of this criterion.   290 
The study did not meet its target of recruiting ≥ 70% of all eligible participants.  However, this 291 
criterion was unrealistically high and 62.50% of all eligible participants were recruited.  Other 292 
CAM studies report a lower participation rate[32] and studies evaluating the effectiveness of 293 
interventions for treating PLP also report a lower participation rate[33].  This study may not 294 
have met its target recruitment rate because it was set unrealistically high.  Participation rate 295 
was good suggesting a future trial would be possible.   296 
Amputees have often undergone extensive unpleasant interventions prior to amputation, and 297 
this may partly explain the reason for those refusing to consent.  The study site may not have 298 
been optimal for recruiting with it being a busy unit providing rehabilitation care for those at a 299 
key life point.  Although, overall, recruitment was good, future studies may benefit by including 300 
amputees who are not in an inpatient unit receiving multiple interventions at a key life point 301 
and by making the proposed intervention less intensive.   302 
Blinding was unsuccessful.  A future study may benefit from clearly including information on 303 
the participant information sheet about the necessity of blinding and should ensure that the 304 
outcome measures used are reliable and objective.  Additionally, a future trial could use 305 
duplicate assessments of outcomes and report the level of agreement between assessors[34].  306 
Also, different data analysts to data collectors could be used.   307 
Establishing acceptability and compliance to an intervention is vital, as if the intervention is 308 
unacceptable and participants not compliant, the study will fail.  This study suggested 309 
acupuncture and usual care were acceptable and participants were compliant with the 310 
protocol.  Unlike usual care alone, acupuncture did appear to be clinically effective at reducing 311 
pain intensity and findings suggested a ‘meaningful change’[23].  This is in keeping with results 312 
from case studies[11] and non-randomised controlled trials[10].  Clinically meaningful change 313 
is important as this is relevant to patient care.  Across a diverse patient group a change of 314 
1.74 on an eleven point NRS has been associated with ‘much improved’ and a change of 2.76 315 
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‘very much improved’[35] suggesting that by the primary end point participants in the 316 
acupuncture group average pain was ‘much improved’ and worst pain was ‘very much 317 
improved’ but this was not so in the usual care group for either average or worst pain.  In 318 
keeping with quantitative findings, qualitatively acupuncture was perceived to be effective at 319 
resolving symptoms.  Findings from this study support the need for a definitive trial to 320 
determine effectiveness.  As less than 8 treatments may be effective this may be a more 321 
appropriate and cost effective dosage.  A usual care control should be used in future studies 322 
as it has the advantage of being safe (physicians make individualised treatment decisions 323 
about participant care) and unlike efficacy trials ensures the intervention can claim to be 324 
superior to usual practice[36].  325 
Unexpectedly practitioners were found to not adhere to the acupuncture protocol.  This lack 326 
of adherence may have been partly due to tensions between clinical and research 327 
workload[29] and due to poor communication with the research team.  This would need 328 
addressing before undertaking a future trial as lack of participants receiving the full intervention 329 
as intended could lead to reduced effectiveness, a decrease in study power and inappropriate 330 
conclusions[37].  Robiner[38] provides a table of adherence enhancing strategies which could 331 
be used in a future trial, including; promoting collaboration and good communication between 332 
acupuncturists and research staff, providing feedback on adherence, promoting non-333 
judgemental discussion around adherence, and addressing adherence problems proactively. 334 
Although adverse events were captured during semi-structured interviews, practitioner 335 
compliance of capture of adverse effects was poor.  This is not uncommon[39] but would need 336 
addressing before undertaking a definitive trial.  Recommendations of capture of adverse 337 
events include capturing the frequency, incidence, timing and severity of each event[40].  A 338 
future study may benefit from giving practitioners a log book designed to capture this 339 
information.   340 
The study identified appropriate outcome measures which could be used in a future trial.  341 
However as the SF-MPQ-2 included some terminology which was not understood, an 342 
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alternative outcome measure may be more appropriate such as the neuropathic pain scale, 343 
the neuropathic pain symptom inventory, or the Pain Quality Assessment Scale[41, 42].  344 
Although participants adhered to completing outcome measures, this was not sustained post 345 
the primary end point of the study.  This lack of long term retention needs addressing as poor 346 
retention has implications on statistical power and the internal and external validity of a 347 
study[43].  Strategies could be implemented such as including; a follow up contact, pre-348 
notification reminders, mentioning an obligation to respond[44].  In randomised controlled trials 349 
offering and giving small monetary incentives has been found to be successful in improving 350 
response[43].  However, lower limb amputees tend to be a frail population and long term 351 
survival post amputation, is poor.  By one year post amputation almost half (44%) of lower 352 
limb amputees will have died and by five years 77%[45].  Additionally, major amputations are 353 
associated with high morbidity and complication rates.  This would need to be taken into 354 
consideration when designing a definitive trial.   355 
Limitations 356 
This study did not consider the effect of attention on symptoms and did not include a control 357 
that mimicked the theoretically inactive elements, but not the active elements of acupuncture.  358 
Further research needs to be carried out to identify optimal dosage, which aspects of 359 
acupuncture intervention causes change and whether environmental factors affect outcomes.  360 
The study did not recruit the number of participants it initially aimed to recruit and quantitative 361 
findings reported in this study should be interpreted with caution.  Only one practitioner was 362 
involved in this study and as differences in effectiveness is known to occur with different 363 
practitioners[46] future studies would benefit from use of multiple practitioners.  Practitioners 364 
did not adhere to the acupuncture protocol and participants were not offered 8 treatments, 365 
making it difficult to determine the effectiveness of the protocol.  Two participants in the 366 
acupuncture group were not interviewed and data saturation of qualitative data cannot be 367 
assumed.   368 
 369 
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CONCLUSIONS 370 
The study provides novel data on the feasibility of conducting a randomised controlled trial to 371 
establish the effectiveness of acupuncture for treating lower limb amputees with PLP.  The 372 
study identified that acupuncture may cause clinically meaningful change.  The protocol used 373 
in this study was acceptable and data on effect size was generated allowing for a sample size 374 
calculation.  Areas which would need addressing prior to undertaking a definitive trial were 375 
identified.   376 
 377 
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 Participant demographics  Acupuncture group 
(n=8) 
Control group (n=7) 
Age mean (± 95% CI) 51.63 (40.38 – 62.87) 55.71 (40.17 -71.26) 
Gender n (%): 
Male 
Female 
 
6 (75) 
2 (25) 
 
2  (28.57) 
5 (71.43) 
Ethnicity n (%): 
White British 
Black Caribbean 
Black African 
White other 
 
 
7 (87.5) 
1 (12.5) 
0 (0) 
0 (0) 
 
 
4 (57.14) 
1 (14.29) 
1 (14.29) 
1 (14.29) 
Employment status n (%): 
Student 
Unemployed 
Sick leave 
Retired 
 
0 (0) 
1 (12.5) 
5 (62.5) 
2 (25) 
 
1 (14.29) 
0 (0) 
3 (42.86) 
3 (42/86) 
Time since amputation in days 
mean (±95% CI) 
 
25.63 (18.43 – 32.85) 29.43 (13.12 – 45.74) 
Level of amputation n (%): 
Above knee 
Below knee 
 
2 (25) 
6 (75) 
 
4 (57.14) 
3 (42.86) 
Reason for amputation n (%): 
Vascular 
Trauma 
Infection 
Other 
 
5 (62.5) 
2 (25) 
0 (0) 
1 (12.5) 
 
3 (42.86) 
2 (28.57) 
1 (14.29) 
1 (14.29) 
 
History of past amputations n (%): 
Yes 
No 
 
 
2 (25) 
6 (75) 
 
 
1 (14.29) 
6 (85.71) 
 
General health n (%): 
Diabetes I 
Diabetes II 
Cancer 
Osteoarthritis 
Epilepsy 
Nil 
 
 
1 (12.5) 
3 (37.5) 
1 (12.5) 
1 (12.5) 
1 (12.5) 
1 (12.5) 
0 (0) 
2 (28.57) 
0 (0) 
0 (0) 
0 (0) 
5 (71.43) 
Mobility level n (%): 
Wheelchair  
 
8 (100) 
 
7 (100) 
 
Table 1 Participant demographics Click here to download Table Table 1.  Participant
demographics.pdf
Outcome measure Group Baseline 
mean  
(± 95% CI)  
Between 
group 
effect 
size 
(Cohen 
d) 
Day 28 
mean  
(± 95% CI) 
Between 
group 
effect 
size 
(Cohen d) 
Number of 
participants who 
provided complete 
data 
Acupuncture 
Usual care 
8 
7 
 7 
5 
 
NRS average pain Acupuncture 5.44 (3.90 - 
6.98) 
0.00 2.75 (0.31 - 
5.19) 
0.64 
  Usual care 5.43 (3.75 - 
7.11) 
  4.43 (2.37 - 
6.49) 
  
NRS worst pain Acupuncture 8.00 (6.21 -
9.79) 
0.38 4.00 (0.40 - 
7.60) 
0.69 
  Usual care 7.29 (5.80 - 
8.77) 
  6.29 (4.54 - 
8.03) 
  
SF-MPQ-2 Acupuncture 2.55 (1.70 - 
3.40) 
0.21 1.06 (0.13 - 
2.24) 
0.46 
  Usual care 2.85 (1.22 -
4.47) 
  1.89 (0.07 - 
3.85) 
  
HADS anxiety Acupuncture 6.38 (2.75 -
10.00) 
0.29 5.25 (1.97 - 
8.53) 
0.10 
  Usual care 5.29 (2.33 - 
8.24) 
  4.86 (1.38 -
8.34) 
  
HADS depression Acupuncture 6.63 (3.34 - 
9.91) 
0.35 5.75 (1.35 - 
10.15) 
0.12 
  Usual care 5.14 (0.99 - 
9.29) 
  5.14 (0.99 - 
9.29) 
  
PSS-10 Acupuncture 15.25 (10.90 
-19.60) 
0.31 11.63 (5.43 - 
17.82) 
0.48 
  Usual care 17.28 (10.11 
- 24.46) 
  15.57 (7.35 - 
23.79) 
  
ISI Acupuncture 13.50 (5.96 - 
21.04) 
0.49 8.50 ( 1.65 - 
15.35) 
0.14 
  Usual care 9.14 (0.93 - 
17.35) 
  7.42 (0.61 - 
14.24) 
  
EQ-5D-5L mobility Acupuncture 4.88 (4.58 - 
5.17) 
0.00 3.75 (2.88 - 
4.62) 
0.47 
  Usual care 4.88 (4.58 - 
5.17) 
  4.29 (3.13 - 
5.45) 
  
EQ-5D-5L self care Acupuncture 1.75 (1.16 - 
2.34) 
0.24 1.63 (1.00 - 
2.25) 
0.09 
Table 2 Statistical data Click here to download Table Table 2.  Statistical data.pdf 
  Usual care 1.57 (0.84 - 
2.30) 
  1.57 (1.08 - 
2.07) 
  
EQ-5D-5L usual 
activities 
Acupuncture 3.75 (2.68 - 
4.82) 
0.45 2.88 (2.18 - 
3.57) 
0.84 
  Usual care 4.29 (3.26 - 
5.31) 
  3.71 (2.69 - 
4.74) 
  
EQ-5D-5L pain - 
discomfort 
Acupuncture 3.50 (2.87 - 
4.13) 
1.24 2.88 (2.18 - 
3.57) 
0.44 
  Usual care 2.71 (2.26 - 
3.17) 
  2.57 (2.08 - 
3.07) 
  
EQ-5D-5L anxiety / 
depression 
Acupuncture 2.00 (1.11 - 
2.89) 
0.46 2.00 (1.23 - 
2.77) 
0.50 
  Usual care 1.57 (0.84 - 
2.30) 
  1.57 (0.84 - 
2.30) 
  
EQ-5D-5L health today Acupuncture 63.13 (46.41 
- 79.84) 
0.21 74.63 (58.49 
- 90.76) 
0.15 
  Usual care 67.14 (50.29 
- 84.00) 
  77.14 (63.05 
- 91.23) 
  
PGIC Acupuncture     5.71 (4.23 - 
7.20) 
1.27 
  Usual care     3.20 (0.37 - 
6.03) 
  
 
  
Theme Quote 
Scepticism and lack of 
expectations 
“I was a bit worried about what it was all about.  You said 
acupuncture and I said I’m not keen on that.  And then I 
thought I’ll try it I’ll try it out.”(Interviewee 1) 
 “Didn't expect it to work.  Very, very very sceptical me, 
very.  That’s how ignorant I was…. I didn’t think it would 
work, I thought it was all nonsense.”(Interviewee 4) 
Being treated “it was so relaxing…. and um I was just lying there and I 
could have quite easily gone to sleep!  It was so relaxing, 
so sort of peaceful”(Interviewee 2)  
Changes in phantom limb 
pain 
“ I said well, it’s good.   It’s very good.....   It works good and 
then last time she came she said aren’t you going to have 
it?  I said no, no, it’s got rid of that pain that was down 
there.”(Interviewee 1) 
Factors affecting treatment “She [the acupuncturist] looked after you well and I think 
that was a lot of it, her personality and the way she treated 
you and everything.”(Interviewee 2) 
"I think because of the environment it was being done in 
and the timing more than anything, I think it wasn’t really a 
positive thing.  It might have been a different story in 
another setting, if I had more time around my 
schedule”(Interviewee 3) 
Completing the outcome 
measures 
“[SF-MPQ-2] A couple of the wordings were a bit weird.  I 
didn’t get some of the words on the describe the pain, 
gruelling and what was the other one, there were a couple 
of them I didn’t understand what these words 
meant.”(Interviewee 4) 
A good experience   “it’s been very positive....  it’s been an extra benefit I would 
definitely say that….  I couldn’t criticise anything to be 
perfectly honest.”(Interviewee 5) 
 
Table 3 Qualitative themes Click here to download Table Table 3. Qualitative themes.pdf 
  
A priori criteria Findings Objective 
met 
(yes / no) 
Recruitment rate was ≥ 2 
participants per month fitting the 
eligibility criteria. 
Recruitment rate was 1.36 eligible participants per 
month. 
No 
The study recruited ≥ 70% of all 
eligible potential participants. 
62.50% of all eligible participants were recruited. No 
Of the participants recruited to 
acupuncture group ≥ 90% 
received their first acupuncture 
treatment within one week of 
recruitment. 
All participants received their first acupuncture 
treatment within a week of recruitment. 
Yes 
After randomisation and allocation 
≥ 90% of participants received 
treatment as initially intended. 
All participants received treatment as intended 
and the study protocol was considered 
acceptable. 
Yes 
Of the participants recruited to 
acupuncture group ≥ 80% 
received all eight acupuncture 
treatments. 
No participants received all 8 treatments (mean 
total number of treatments 5.14 (4.02 – 6.27)). 
No 
Of the participants recruited to 
usual care group ≤ 10% dropped 
out of the study. 
One participant (14.29%) of participants dropped 
out of the usual care group. 
No 
At the primary endpoint of the 
study outcome measures were 
completed by ≥ 90% of 
participants. 
100% of participants still enrolled on the study 
completed all outcome measures by the primary 
endpoint of the study. 
Yes 
At one month after completion of 
the study, outcome measures 
were completed by ≥ 60% of 
participants. 
Outcome measures were completed by 5 
participants (33.33%) 
No 
Qualitative data identified that 
outcome measures were 
acceptable and appropriate, that 
questionnaires and rating scales 
were easy to complete and that 
outcome measures could be 
identified for use in a definitive 
trial. 
Outcome measures were considered acceptable, 
appropriate and easy to complete.  The HADS, 
PSS-10, EQ-5D-5L and ISI may not be 
appropriate for use in a definitive trial. 
Yes 
Qualitative data implied that 
acupuncture was an acceptable 
and effective intervention for 
treating PLP with or without other 
secondary symptoms. 
 Acupuncture / electro-acupuncture was 
considered acceptable.  Acupuncture was 
perceived to be effective at treating both PLP and 
other secondary complaints.  
Yes 
Table 4 Success of the feasibility study Click here to download Table Table 4. Success of the
feasibility study.pdf
Data was collected on the primary 
outcome measure (NRS) and 
effect size was calculated to 
inform a sample size calculation 
for a larger trial. 
Considering a 20% dropout rate, 170 participants 
are recommended to be recruited to detect a 
significant change in a two armed parallel 
randomised controlled trial comparing usual care 
and acupuncture as measured using an 11 point 
NRS measuring average pain at four weeks. 
Yes 
Qualitative and quantitative data 
implied the acupuncture protocol 
used in the feasibility study was 
appropriate for use in a definitive 
multi-centred randomised 
controlled trial. 
Participants did not drop out of the acupuncture 
group suggesting it was acceptable.  Participants 
symptoms generally improved over 6 treatments 
suggesting 8 treatments was adequate.  
Acupuncture and electro-acupuncture were 
considered acceptable, effective and relaxing. 
Yes 
The researcher was not aware 
which group participants had 
been enrolled to 100% of the 
time. 
Blinding was not successful and the researcher 
knew through both participants and clinical staff at 
the amputee unit their group allocation. 
No 
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Lower limb amputees 
approached (n=36)
Number eligible (n=24)
Reasons for ineligibility:
• PLP < 5/10 (n=9)
• Medically unwell (n=1)
• Poor cognitive function 
(n=2)
Participants enrolled and 
randomised (n=15)
Dropped out:
• Not allocated to 
acupuncture group 
(n=1)
Acupuncture 
group (n=8)
Usual care 
group (n=7)
Dropped out:
• Upset as not getting 
prosthesis (n=1)
• When discharged home 
(n=1)
Participants 
interviewed 
(n=5)
Participants 
completed 1 
month follow 
up  (n=4)
Number ineligible (n=12)
Withdrawn:
• Medically unwell (n=1)
Participants 
completed 
outcomes at 
primary end 
point (n=7)
Participants 
completed 
outcomes at 
primary end 
point (n=5)
Participants 
completed 1 
month follow 
up  (n=1)
Dropped out 
(n=4)
Dropped out 
(n=1)
Withdrawn:
• Medically unwell (n=1)
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8
)
Pre-randomisation 
withdrawn:
• Worried study would 
interfere with visiting 
times (n=1)
• Unwilling to fill in 
questionnaires (n=1)
• Unwilling to be involved 
in a clinical trial (n=4)
• Unwilling to have 
acupuncture until it has 
been proven effective 
PLP (n=2)
• Unwilling to have 
unnecessary additional 
interventions (n=4)
• Refused to be 
randomised (n=1)
• Afraid of needles (n=1)
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o
n
th
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Figure 1 Participant flow Click here to download Figure Participant flow chart
(1).pdf
  
 
Figure 2 Boxplot average pain intensity Click here to download Figure Box plot NRS average pain
intensity.pdf
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